|
CHM |
CFO certification of the 03-31-2024 quarterly filing |
Autre |
15/05/2024 |
 Open Filing (139.84 Ko) |
|
RWB |
Financial Statements Request Form |
Autre |
15/05/2024 |
Open Filing (97.37 Ko) |
|
CHM |
MD&A for the quarter ended March 31, 2024, as filed 05/15/2024 |
MD & A (Discussion et analyse de la direction) |
15/05/2024 |
Open Filing (419 Ko) |
|
RWB |
FORM OF PROXY |
Formulaire de procuration |
15/05/2024 |
Open Filing (132.52 Ko) |
|
RWB |
RED WHITE & BLOOM BRANDS INC. NOTICE AND ACCESS NOTIFICATION TO SHAREHOLDERS ANNUAL GENERAL & SPECIAL MEETING OF SHAREHOLDERS |
Avis de convocation |
15/05/2024 |
Open Filing (140.72 Ko) |
|
CHM |
Quarterly financial statements for the period ended March 31, 2024 |
États financiers intermédiaires |
15/05/2024 |
Open Filing (435.3 Ko) |
|
RWB |
RED WHITE & BLOOM BRANDS INC. Notice and Information Circular |
Management Proxy / circulaire d'information |
15/05/2024 |
Open Filing (2.19 Mo) |
|
CHM |
Form 5 - Quarterly Listing Statement quarter-ended 03-31-2024 |
Déclaration d'inscription trimestrielle |
15/05/2024 |
Open Filing (858.37 Ko) |
|
BIOV |
BioVaxys Technology Corp. – CSE Form 6 – Certificate of Compliance |
Certificat de conformité |
15/05/2024 |
Open Filing (102.32 Ko) |
|
BIOV |
BioVaxys Technology Corp. – CSE Form 9 – Notice of Issuance or Proposed Issuance of Listed Securities |
Émission proposée des titres cotés |
15/05/2024 |
Open Filing (210.94 Ko) |
